THOUSAND OAKS, Calif., Aug. 28, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the presentation of 14 cardiovascular scientific research abstracts, including studies evaluating the safety and efficacy of Repatha® (evolocumab) by race and ethnicity and further examining its clinical benefit in patients with familial hypercholesterolemia (FH)

RISHIKESH, India, Aug. 28, 2019 /PRNewswire/ --  HEMPCORP envisions a green future and aims to provide global consumers with the best alternative organic medicine available by utilising hemp sourced cannabinoids and terpenes.

CEDAR FALLS, Iowa, Aug. 28, 2019 /PRNewswire/ -- St. Croix Hospice is pleased to announce the opening of an office in Cedar Falls, Iowa in response to a need for additional hospice services in the community and surrounding area.

OMAHA, Neb., Aug. 28, 2019 /PRNewswire/ -- Jisella Dolan, Global Chief Advocacy Officer at Home Instead, Inc., has been appointed to the

PITTSBURGH, Aug. 28, 2019 /PRNewswire/ -- The ranks of Medicare Advantage (MA) Plans are growing not only in number, but also in sophistication, observes Patrick Phillips, CEO of Cavulus, a leading technology firm that serves the MA industry.

NEW YORK, Aug. 28, 2019 /PRNewswire/ -- Tiber Health is opening access to healthcare education to help create more medical professionals in communities that desperately need them. In years past, the high costs, high stress, and high expectations of health science education have caused more students to drop out or fail their Board exams, resulting in a growing s

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 /PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of therapeutic resistance, announced today that it will be participating in Citi's 14th Annual Biotech Conference in Boston.  On Wednesday,

AUSTIN, Texas, Aug. 28, 2019 /PRNewswire/ -- Harmonic Bionics, Inc. announced today that Christopher Prentice has been appointed Chief Executive Officer

SEATTLE, Aug. 28, 2019 /PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense announced today that Kineta's management team has been invited to participate at H.C. Wainwright 21st Annual Global Investment Conference in New York,

NEW YORK, Aug. 28, 2019 /PRNewswire/ -- The Mesothelioma Compensation Center is extremely concerned about people with mesothelioma getting overcharged by a